Multiple Ascending Doses of SY-009 in Type 2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

April 29, 2021

Study Completion Date

September 21, 2021

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

SY-009

The subjects were admitted to the clinical trial center two days before the administration period (D-2), fasted for 10 hours overnight on the day before the Administration (D-1), and banned water for 1 hour before the administration. Take sy-009 test drug or placebo immediately before meal (QD is before breakfast, bid is before breakfast and dinner) in the morning of the first day of administration, and deliver it with not more than 200ml warm boiled water. From the day 2 (D2) to the day 7 (D7) before dinner, the oral cavity of the subjects was checked for residual drugs after each administration.

DRUG

SY-009 matching placebo

SY-009 matching placebo

Trial Locations (4)

210093

Nanjing Drum Tower Hospital, Nanjing

230601

The Second Affiliated Hospital of Anhui Medical University, Hefei

266000

Affiliated Hospital of Qingdao University, Qingdao

044000

Yuncheng Central Hospital, Yuncheng

All Listed Sponsors
lead

Suzhou Yabao Pharmaceutical R&D Co., Ltd.

INDUSTRY

NCT04345107 - Multiple Ascending Doses of SY-009 in Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter